Elaine Quilici is a freelance writer for 

Miranda Schmalfuhs is the associate group social media editor of 

Pharmaceutical Executive, Pharmaceutical Commerce

 and can be reached at mschmalfuhs@mjhlifesciences.com.

Dr. Michael Henderson, Chief Business Officer of BridgeBio Pharma, talks about how his company is partnering with academia in a novel way to develop important programs that might otherwise be dropped.

Editorial Podcasts

Dr. Michael Henderson, chief business officer of BridgeBio Pharma, and one of Pharm Exec’s 2021 Emerging Pharma Leaders, discusses how his company goes beyond the traditional “hand off” approach between academia and industry, and looks to partner with institutions early on to fill important voids in drug development.

Episode 91: A New Way to Partner With Academia